Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Year-over-year earnings per share growth rate
Latest
0.00%
↓ 100% vs avg
Percentile
P44
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
0.91%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | 36.59% |
| Q2 2025 | 2.38% |
| Q1 2025 | -10.53% |
| Q4 2024 | 11.63% |
| Q3 2024 | 6.52% |
| Q2 2024 | -9.52% |
| Q1 2024 | 12.50% |
| Q4 2023 | -6.67% |
| Q3 2023 | 16.67% |
| Q2 2023 | 1.82% |
| Q1 2023 | -25.00% |
| Q4 2022 | 29.03% |
| Q3 2022 | -16.98% |
| Q2 2022 | 13.11% |
| Q1 2022 | 14.08% |
| Q4 2021 | -7.58% |
| Q3 2021 | -13.79% |
| Q2 2021 | -23.40% |
| Q1 2021 | 7.84% |
| Q4 2020 | -15.91% |
| Q3 2020 | -46.67% |
| Q2 2020 | -3.45% |
| Q1 2020 | 6.45% |
| Q4 2019 | -47.62% |
| Q3 2019 | 93.88% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |